Recurrent neuromyelitis optica in Brazilian patients: Clinical, immunological, and neuroimaging characteristics

Multiple Sclerosis

Volumn 16, Issue 1, 2010, Pages 81-86

  Adoni, T ^a   Lino, A M M ^a   Da Gama, P D ^a   Apostolos Pereira, S L ^a   Marchiori, P E ^a   Kok, F ^a   Callegaro, D ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazilian patients; Clinical features; Devics; Imaging; Neuromyelitis optica; NMO IgG

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BRAZIL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; EXPANDED DISABILITY STATUS SCALE; FATALITY; FEMALE; FOLLOW UP; HUMAN; HYPERPROLACTINEMIA; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MYASTHENIA GRAVIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; RESPIRATORY FAILURE; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE OF ONSET; BRAIN; BRAZIL; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; RECURRENCE; YOUNG ADULT;

EID: 73949134865     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509353651     Document Type: Article

References (40)

1. Jacob A., Matiello M., Wingerchuk DM, Luchinetti CF, Pittock SJ, Weinshenker BG Neuromyelitis optica: Changing concepts. J Neuroimmunol 2007 ; 187: 126 138.
2. Mandler RN, Davis LE, Jeffery DR, Kornfeld MK Devics neuromyelitis optica: a clinical pathological study of 8 patients. Ann Neurol 1993 ; 34: 162 168.
3. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004 ; 364: 2106 2112.
4. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SH IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005 ; 202: 473 477.
5. Zuliani L., Blanco Y., Tavolato B., Giometto B., Graus F., Saiz A. Neuromyelitis optica autoantibody (NMO-IgG) in patients with suspected NMO or limited forms of NMO. Mult Scler 2006 ; 12: S155.
6. Littleton ET, Jacob A., Boggild M., Palace J. An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica. Mult Scler 2006 ; 12: S156.
7. Kim KK NMO-IgG and opticospinal multiple sclerosis and idiopathic recurrent myelitis. Mult Scler 2006 ; 12: S157.
8. Marignier R., De Seze J., Durand-Dubief F., et al. NMO-IgG: a French experience. Mult Scler 2006 ; 12: S4.
9. Jarius S., Franciotta D., Bergamaschi R., et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007 ; 68: 1076 1077.
10. Akman-Demir G., Mutlu M., Icoz S., Kurtuncu M., Yesilot N., Eraksoy M. Probable NMO-IgG in Turkish patient with Devics disease, and multiple sclerosis. Mult Scler 2006 ; 12: S157.
11. Adoni T., Lino AMM, Marchiori PE, Kok F., Callegaro D. Seroprevalence of NMO-IgG antibody in Brazilian patients with neuromyelitis optica. Arq Neuropsiquiatr 2008 ; 66 (2B). 295 297.
12. Wingerchuk DM, Hogancamp WF, OBrien PC, Weinshenker BG The clinical course of neuromyelitis optica (Devics syndrome). Neurology 1999 ; 53: 1107 1114.
13. Polman CH, Reingold SC, Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Ann Neurol 2005 ; 58: 840 846.
14. Osuntokun BO The pattern of neurological illness in tropical Africa: experience at Ibadan, Nigeria. J Neurol Sci 1971 ; 12: 417 442.
15. Modi G., Mochan A., Modi M., Saffer D. Demyelinating disorder of the central nervous system occurring in Black South Africans. J Neurol Neurosurg Psychiatry 2001 ; 70: 500 505.
16. Kira JI, Kanai T., Nishimura Y., et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996 ; 40: 569 574.
17. Kira JI Multiple sclerosis in the Japanese population. Lancet Neurol 2003 ; 2: 117 127.
18. Hung TP, Landsborough D., His MS Multiple sclerosis amongst Chinese in Taiwan. J Neurol Sci 1976 ; 27: 759 784.
19. Tan CT Multiple sclerosis in Malaysia. Arch Neurol 1988 ; 45: 624 627.
20. Lana-Peixoto MA, Lana-Peixoto MI Is multiple sclerosis in Brazil and Asia alike? Arq Neuropsiquiatr 1992 ; 50: 419 425.
21. Papais-Alvarenga, Miranda-Santos CM, Puccioni-Sohler M., et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 2002 ; 73: 429 435.
22. Lana-Peixoto MA Devics neuromyelitis optica: a critical review. Arq Neuropsiquiatr 2008 ; 66: 120 138.
23. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG Revised diagnostic criteria for neuromyelitis optica. Neurology 2006 ; 66: 1485 1489.
24. Lau KK, Wong LKS, Li LSW, Chan YW, Li HI, Wong V. Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey. Hong Kong Med J 2002 ; 8: 77 80.
25. Wingerchuck DM, Weinshenker BG Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003 ; 60: 848 853.
26. Parra FC, Amado RC, Lambertucci JR, Rocha J., Antunes CM, Pena SDJ Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003 ; 100: 177 182.
27. Staugaitis SM, Roberts JK, Sacco RL, Miller JR, Dwork AJ Devic-type multiple sclerosis in an 81-year old woman. J Neurol Neurosurg Psychiatry 1998 ; 64: 417 418.
28. Merle H., Olindo S., Bonnan M., et al. Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology 2007 ; 114: 810 815.
29. Matsuoka T., Matsushita T., Kawano Y., et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007 ; 130: 1206 1223.
30. Pittock SJ, Lennon VA, Wingerchuk DM, Homburger HA, Lucchinetti CF, Weinshenker BG The prevalence of non-organ-specific auto antibodies and NMO IgG in neuromyelitis optica (NMO) and related disorders. Neurology 2006 ; 66: A37.
31. Vernant JC, Cabre P., Smadja D., Merle H., Caubarrere I., Mikol J., et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 1997 ; 45: 58 64.
32. Yamasaki K., Horiuchi I., Minohara M., Osoegawa M., Kawano Y., Ohyagi Y., et al. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med 2000 ; 39: 296 299.
33. Kister I., Gulati S., Boz C., Bergamaschi R., Piccolo G., Oger J., et al. Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy. Arch Neurol 2006 ; 63: 851 856.
34. McKeon A., Lennon VA, Jacob A., Matiello M., Lucchinetti CF, Kale N., et al. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 2009 ; 39: 87 90.
35. Birnbaum J., Kerr D. Devics syndrome in a woman with systemic lupus erythematosus: diagnostic and therapeutic implications of testing for the neuromyelitis optica IgG autoantibody. Arthritis Rheum 2007 ; 57: 347 351.
36. ORiordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DP, Thompson EJ, et al. Clinical, CSF, and MRI findings in Devics neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996 ; 60: 382 387.
37. Nakashima I., Fujihara K., Miyazawa I., Misu T., Narikawa K., Nakamura M., et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry. 2006 ; 77: 1073 1075.
38. Bichuetti DB, Oliveira EML, Souza NA, Rivero RLM, Gabbai AA Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. Mult Scler 2009 ; 15: 613 619.
39. Weinshenker BG, Wingerchuk DM, Vukusic S., Linbo L., Pittock SJ, Lucchinetti CF, et al. Neuromyelitis optica IgG predicts relapse after extensive transverse myelitis. Ann Neurol 2006 b; 59: 566 569.
40. Misu T., Fujihara K., Kakita A., Konno H., Nakamura M., Watanabe S., et al. Loss of aquaporin-4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007 ; 130: 1224 1234.